A detailed history of Integrated Investment Consultants, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 694,167 shares of LLY stock, worth $552 Million. This represents 13.53% of its overall portfolio holdings.

Number of Shares
694,167
Previous 1,864 37140.72%
Holding current value
$552 Million
Previous $1.69 Million 36354.65%
% of portfolio
13.53%
Previous 0.49%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $535 Million - $665 Million
692,303 Added 37140.72%
694,167 $615 Million
Q1 2024

Apr 18, 2024

SELL
$592.2 - $792.28 $1,776 - $2,376
-3 Reduced 0.16%
1,864 $1.45 Million
Q4 2023

May 28, 2024

SELL
$525.19 - $619.13 $8,403 - $9,906
-16 Reduced 0.85%
1,863 $1.09 Million
Q4 2023

Jan 23, 2024

SELL
$525.19 - $619.13 $8,403 - $9,906
-16 Reduced 0.85%
1,867 $1.09 Million
Q3 2023

May 28, 2024

BUY
$434.7 - $599.3 $6,520 - $8,989
15 Added 0.8%
1,879 $1.01 Million
Q3 2023

Oct 17, 2023

SELL
$434.7 - $599.3 $71,290 - $98,285
-164 Reduced 8.01%
1,883 $1.01 Million
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $321,277 - $429,585
916 Added 80.99%
2,047 $960,000
Q1 2023

Jul 18, 2023

BUY
$310.63 - $364.82 $85,423 - $100,325
275 Added 13.43%
2,322 $797,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $97,429 - $113,525
303 Added 36.59%
1,131 $413,000
Q3 2022

Nov 21, 2022

SELL
$296.48 - $337.87 $55,145 - $62,843
-186 Reduced 18.34%
828 $268,000
Q2 2022

Jul 19, 2022

SELL
$278.73 - $327.27 $53,794 - $63,163
-193 Reduced 15.99%
1,014 $329,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $22,060 - $27,416
94 Added 8.45%
1,207 $346,000
Q4 2021

Jan 10, 2022

BUY
$224.85 - $279.04 $7,644 - $9,487
34 Added 3.15%
1,113 $307,000
Q3 2021

Oct 28, 2021

BUY
$221.6 - $272.71 $2,216 - $2,727
10 Added 0.94%
1,079 $249,000
Q2 2021

Jul 21, 2021

SELL
$180.55 - $233.54 $93,163 - $120,506
-516 Reduced 32.56%
1,069 $245,000
Q2 2018

Aug 01, 2018

SELL
$75.7 - $86.88 $6,283 - $7,211
-83 Reduced 4.98%
1,585 $135,000
Q1 2018

Apr 12, 2018

BUY
$74.21 - $87.6 $12,467 - $14,716
168 Added 11.2%
1,668 $129,000
Q3 2017

Oct 26, 2017

BUY
$77.07 - $85.54 $115,604 - $128,310
1,500
1,500 $128,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Integrated Investment Consultants, LLC Portfolio

Follow Integrated Investment Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.